Literature DB >> 18022114

Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy.

Quirino Ciampi1, Sandro Betocchi, Maria Angela Losi, Adele Ferro, Alberto Cuocolo, Raffaella Lombardi, Bruno Villari, Massimo Chiariello.   

Abstract

BACKGROUND: Abnormal blood-pressure response during exercise occurs in about one third of patients with hypertrophic cardiomyopathy (HCM), and it has been associated with a high risk of sudden cardiac death. We assessed the hemodynamics of exercise in HCM patients with abnormal blood-pressure response by using ambulatory radionuclide monitoring (VEST) of left-ventricular (LV) function, and exercise tolerance by oxygen consumption.
METHODS: Twenty-two HCM patients underwent treadmill exercise during VEST monitoring. A cardiopulmonary exercise test was performed a few days after. The VEST data were averaged for 1 minute. Stroke volume, cardiac output, and systemic vascular resistance were expressed as percent of baseline. Exercise tolerance was assessed as maximal oxygen consumption.
RESULTS: In eight HCM patients (36%) with an abnormal blood-pressure response, end-systolic volume increased more (52% +/- 21% vs 31% +/- 28%, P = .012), and the ejection fraction (-31% +/- 17% vs -14% +/- 22%, P = .029) and stroke volume (-21% +/- 21% vs 3% +/- 28%, P = .026) fell more, than in patients with normal response. Cardiac output increased less in the former patients (49% +/- 44% vs 94% +/- 44%, P = .012). Systemic vascular resistance decreased similarly, irrespective of blood-pressure response (-28% +/- 26% vs -34% +/- 26%, P = N.S.). Percent of maximal predicted oxygen consumption was lower in HCM patients with an abnormal blood-pressure response (63% +/- 11% vs 78% +/- 15%, P = .025).
CONCLUSIONS: In HCM patients, abnormal blood-pressure response was associated with exercise-induced LV systolic dysfunction and impairment in oxygen consumption. This may cause hemodynamic instability, associated with a high risk of sudden cardiac death.

Entities:  

Mesh:

Year:  2007        PMID: 18022114     DOI: 10.1016/j.nuclcard.2007.08.003

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  34 in total

1.  Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy.

Authors:  J A Panza; R K Petrone; L Fananapazir; B J Maron
Journal:  J Am Coll Cardiol       Date:  1992-01       Impact factor: 24.094

2.  Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome.

Authors:  M Yamada; P M Elliott; J C Kaski; K Prasad; J N Gane; C M Lowe; Y Doi; W J McKenna
Journal:  Eur Heart J       Date:  1998-03       Impact factor: 29.983

3.  Color Doppler assessment of mitral regurgitation with orthogonal planes.

Authors:  F Helmcke; N C Nanda; M C Hsiung; B Soto; C K Adey; R G Goyal; R P Gatewood
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

4.  Hypertrophic cardiomyopathy: a discussion of nomenclature.

Authors:  B J Maron; S E Epstein
Journal:  Am J Cardiol       Date:  1979-06       Impact factor: 2.778

5.  Exercise-induced hypotension in a male population. Criteria, causes, and prognosis.

Authors:  P Dubach; V F Froelicher; J Klein; D Oakes; M Grover-McKay; R Friis
Journal:  Circulation       Date:  1988-12       Impact factor: 29.690

6.  Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy.

Authors:  J J Kim; C W Lee; S W Park; M K Hong; H Y Lim; J K Song; Y S Jin; S J Park
Journal:  Am J Cardiol       Date:  1999-04-15       Impact factor: 2.778

7.  Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy.

Authors:  K Okeie; M Shimizu; H Yoshio; H Ino; M Yamaguchi; T Matsuyama; T Yasuda; J Taki; H Mabuchi
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

8.  Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.

Authors:  N Yoshida; H Ikeda; T Wada; A Matsumoto; S Maki; A Muro; A Shibata; T Imaizumi
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

9.  Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy.

Authors:  P J Counihan; M P Frenneaux; D J Webb; W J McKenna
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

10.  Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

Authors:  P T O'Gara; R O Bonow; B J Maron; B A Damske; A Van Lingen; S L Bacharach; S M Larson; S E Epstein
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

View more
  9 in total

1.  Exercise in hypertrophic cardiomyopathy.

Authors:  Sharlene M Day
Journal:  J Cardiovasc Transl Res       Date:  2009-10-14       Impact factor: 4.132

2.  Relation of pulse pressure to blood pressure response to exercise in patients with hypertrophic cardiomyopathy.

Authors:  Kevin S Heffernan; Martin S Maron; Eshan A Patvardhan; Richard H Karas; Jeffrey T Kuvin
Journal:  Am J Cardiol       Date:  2010-12-22       Impact factor: 2.778

3.  Left Ventricular Mass in Hypertrophic Cardiomyopathy Assessed by 2D-Echocardiography: Validation with Magnetic Resonance Imaging.

Authors:  Maria Angela Losi; Massimo Imbriaco; Grazia Canciello; Filomena Pacelli; Carlo Di Nardo; Raffaella Lombardi; Raffaele Izzo; Costantino Mancusi; Andrea Ponsiglione; Serena Dell'Aversana; Alberto Cuocolo; Giovanni de Simone; Bruno Trimarco; Emanuele Barbato
Journal:  J Cardiovasc Transl Res       Date:  2019-09-05       Impact factor: 4.132

4.  Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a 13NH3 gated PET study.

Authors:  Roberto Sciagrà; Raffaella Calabretta; Fabrizio Cipollini; Alessandro Passeri; Angelo Castello; Franco Cecchi; Iacopo Olivotto; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-01-03       Impact factor: 9.236

5.  Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations.

Authors:  Marshall Heradien; Miriam Revera; Lize van der Merwe; Althea Goosen; Valerie A Corfield; Paul A Brink; Bongani M Mayosi; Johanna C Moolman-Smook
Journal:  Heart Rhythm       Date:  2009-09-01       Impact factor: 6.343

6.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

7.  Effects of lifestyle changes and high-dose β-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy.

Authors:  Ewa-Lena Bratt; Ingegerd Östman-Smith
Journal:  Cardiol Young       Date:  2014-03-10       Impact factor: 1.093

8.  Left ventricular diastolic gradient in hypertrophic cardiomyopathy.

Authors:  Filomena Pacelli; Antonio Rapacciuolo; Alessandra Giamundo; Grazia Canciello; Anna Franzone; Massimo Imbriaco; Bruno Trimarco; Maria-Angela Losi
Journal:  Int J Cardiol Heart Vasc       Date:  2016-11-29

Review 9.  Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.

Authors:  Adrián Bayonas-Ruiz; Francisca M Muñoz-Franco; Vicente Ferrer; Carlos Pérez-Caballero; María Sabater-Molina; María Teresa Tomé-Esteban; Bárbara Bonacasa
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.